Conversion surgery following trastuzumab and docetaxel combination therapy for unresectable HER2-positive parotid gland cancer. - Kano S; Taguchi J; Maeda T; Suzuki T; Hamada S; Kato S; Saito A; Shimizu Y; Homma A (Auris, nasus, larynx, 2026)